Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
INACTIVE
Global HQ
China
Countries of investment
  • Portugal
Investment stages
  • Seed
Industries
    About
    3E Bioventures is a venture Capital firm based in Beijing, China, specializing in growth Capital. The firm focuses on the healthcare sector, investing in early and late stage ventures within drug development, medical devices, diagnostics, healthcare IT, and medical services. Founded in 2015 by Karen Liu, 3E Bioventures leverages its team's deep biomedical expertise and extensive industry experience to identify and nurture promising healthcare startups in China and overseas. The firm manages both RMB and US Dollar funds, reflecting its commitment to global investment opportunities.,
    Min check size
    $100K
    Max check size
    $1M
    Fund size
    NPS

    Investment Thesis

    3E Bioventures is dedicated to Capitalizing on the significant growth potential in the Chinese healthcare industry over the next 10 to 20 years. The firm aims to leverage its team's biomedical Training and healthcare industry experience to support early and growth stage companies. By combining a global industry perspective with practical ontheground experience in China, 3E Bioventures seeks to build successful healthcare ventures and technologies that generate substantial returns for investors. The firm is committed to fostering innovation in the healthcare sector and establishing itself as a leading international healthcare investment brand.,
    Lead investor
    Co Invest
    Number of exits
    Preferred contact method

    Portfolio

    Rapafusyn Pharmaceuticals

    Cellbri

    Arnatar Therapeutics

    Tianhu Technology

    varnotech

    Myrobalan Therapeutics

    Jushu Biotech

    Smartlens

    Novlead Biotech

    Eaglenos

    Dermaliq Therapeutics

    Cardea Bio

    Lipidio Pharmaceuticals

    Ansun BioPharma

    Profusa

    C4 Therapeutics

    Cytek Biosciences

    Biocytogen

    MicuRx Pharmaceuticals

    Apexigen

    OncoImmune

    Fund number
    Vintage Year
    Net Internal Rate of Return
    Investment Multiple
    Capital Allocation
    Management Fee
    Carried Interest
    AUM
    Follow-on Investments
    Graduation Rate
    Write-Off Ratio
    Last profile update timestamp